Related references
Note: Only part of the references are listed.Prototype of running clinical trials in an untrustworthy environment using blockchain
Daniel R. Wong et al.
NATURE COMMUNICATIONS (2019)
A Retrospective Analysis of Clinical Research Misconduct Using FDA-Issued Warning Letters and Clinical Investigator Inspection List From 2010 to 2014
Christopher A. Romano et al.
ANESTHESIA AND ANALGESIA (2018)
Noncommercial Funders Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability
Nicholas J. DeVito et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
A comparison of approaches for adjudicating outcomes in clinical trials
Brennan C. Kahan et al.
TRIALS (2017)
Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium
Jonathan H. Seltzer et al.
AMERICAN HEART JOURNAL (2017)
Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals
J. B. Carlisle
ANAESTHESIA (2017)
The Majority of Expedited Investigational New Drug Safety Reports Are Uninformative
Jonathan P. Jarow et al.
CLINICAL CANCER RESEARCH (2016)
Impact of Cancer Research Bureaucracy on Innovation, Costs, and Patient Care
David P. Steensma et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Share Paper
